<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Orforglipron on Foundation Wellness | TRT, Hormones &amp; Weight Loss, Utah</title><link>https://foundationmedicalwellness.com/tags/orforglipron/</link><description>Recent content in Orforglipron on Foundation Wellness | TRT, Hormones &amp; Weight Loss, Utah</description><generator>Hugo</generator><language>en-us</language><copyright>Foundation Wellness. All rights reserved.</copyright><lastBuildDate>Sat, 07 Nov 2026 00:00:00 +0000</lastBuildDate><atom:link href="https://foundationmedicalwellness.com/tags/orforglipron/index.xml" rel="self" type="application/rss+xml"/><item><title>GLP-1 Weight Loss for Non-Diabetic Adults: Who Qualifies</title><link>https://foundationmedicalwellness.com/glp-1-weight-loss-non-diabetic/</link><pubDate>Sat, 07 Nov 2026 00:00:00 +0000</pubDate><guid>https://foundationmedicalwellness.com/glp-1-weight-loss-non-diabetic/</guid><description>&lt;p>Yes. If you&amp;rsquo;re non-diabetic, you can still be prescribed a GLP-1 medicine for weight loss. The FDA approves these medicines for chronic weight management in adults with obesity, or overweight plus at least one weight-related condition, used with a reduced-calorie diet and more physical activity. Wegovy, Zepbound, Saxenda and the new Foundayo tablet all carry that label.&lt;/p>
&lt;p>So where are the lines? &lt;a href="https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity">NIDDK&lt;/a> puts them at a BMI of 30 or higher, or 27 or higher with a weight-related problem such as high blood pressure.&lt;/p></description></item></channel></rss>